XML 127 R70.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Debt, cash and cash equivalents and lease liabilities (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
Financial Instruments [Abstract] |
Summary of Changes in Financial Position | Changes in Sanofi's financial position during the period were as follows:
(€ million) | 2024 | 2023 | 2022
Long-term debt | 11,791 | 14,347 | 14,857
Short-term debt and current portion of long-term debt | 4,209 | 2,045 | 4,174
Interest rate and currency derivatives used to manage debt | 137 | 139 | 187
Total debt | 16,137 | 16,531 | 19,218
Cash and cash equivalents | (7,441) | (8,710) | (12,736)
Interest rate and currency derivatives used to manage cash and cash equivalents | 76 | (28) | (45)
Net debt(a) | 8,772 | 7,793 | 6,437
(a)Net debt does not include lease liabilities, which amounted to €1,906 million as of December 31, 2024, €2,030 million as of December 31, 2023, and €2,181 million as of December 31, 2022 (see the maturity analysis at Note D.17.2.).
Summary of Reconciliation of Carrying Amount to Value on Redemption | Reconciliation of carrying amount to value on redemption
|  |  |  | Value on redemption
(€ million) | Carrying amount at December 31, 2024 | Amortized cost | Adjustment to debt measured at fair value | December 31, 2024 | December 31, 2023 | December 31, 2022
Long-term debt | 11,791 | 30 | 119 | 11,940 | 14,546 | 15,143
Short-term debt and current portion of long-term debt | 4,209 | 4 | 5 | 4,218 | 2,045 | 4,178
Interest rate and currency derivatives used to manage debt | 137 |  | (124) | 13 | (18) | (48)
Total debt | 16,137 | 34 | — | 16,171 | 16,573 | 19,273
Cash and cash equivalents | (7,441) |  |  | (7,441) | (8,710) | (12,736)
Interest rate and currency derivatives used to manage cash and cash equivalents | 76 |  |  | 76 | (28) | (45)
Net debt | 8,772 | 34 | — | 8,806 | 7,835 | 6,492
Disclosure of Movement In Total Debt | The table below shows the movement in total debt during the period:
|  | Cash flows from financing activities | Non-cash items |
(€ million) | December 31, 2023 | Repayments | New borrowings | Other cash flows(a) | Currency translation differences(b) | Reclassification from non-current to current | Other items(c) | December 31, 2024
Long-term debt | 14,347 | (67) | — | — | 63 | (2,599) | 47 | 11,791
Short-term debt and current portion of long-term debt | 2,045 | (605) | — | 242 | 9 | 2,599 | (81) | 4,209
Interest rate and currency derivatives used to manage debt | 139 | — | — | (132) | 146 | — | (16) | 137
Total debt | 16,531 | (672) | — | 110 | 218 | — | (50) | 16,137
(a)These amounts mainly comprise €262 million related to the US commercial paper program. (b)These amounts include gains and losses, and the impact of foreign currency translation of the financial statements of subsidiaries outside the Euro zone. (c)These amounts mainly comprise changes in accrued interest balances, and fair value adjustments. The table below shows the movement in total debt during prior periods:
|  | Cash flows from financing activities | Non-cash items |
(€ million) | December 31, 2022 | Repayments | New borrowings | Other cash flows(a) | Currency translation differences(b) | Reclassification from non-current to current | Other items(c) | December 31, 2023
Long-term debt | 14,857 | (12) | 48 | — | (30) | (604) | 88 | 14,347
Short-term debt and current portion of long-term debt | 4,174 | (3,672) | — | 903 | (21) | 604 | 57 | 2,045
Interest rate and currency derivatives used to manage debt | 187 | — | — | (8) | 29 | — | (69) | 139
Total debt | 19,218 | (3,684) | 48 | 895 | (22) | — | 76 | 16,531
(a)These amounts mainly comprise €946 million related to the US commercial paper program. (b)These amounts include gains and losses, and the impact of foreign currency translation of the financial statements of subsidiaries outside the Euro zone. (c)These amounts mainly comprise changes in accrued interest balances, and fair value adjustments.
|  | Cash flows from financing activities | Non-cash items |
(€ million) | December 31, 2021 | Repayments | New borrowings | Other cash flows | Currency translation differences (a) | Reclassification from non-current to current | Other items(b) | December 31, 2022
Long-term debt | 17,123 | (11) | 1,549 | — | 56 | (3,632) | (228) | 14,857
Short-term debt and current portion of long-term debt | 3,183 | (2,707) | — | 43 | 20 | 3,632 | 3 | 4,174
Interest rate and currency derivatives used to manage debt | (56) | — | — | (373) | 366 | 7 | 243 | 187
Total debt | 20,250 | (2,718) | 1,549 | (330) | 442 | 7 | 18 | 19,218
(a)These amounts include gains and losses, and the impact of foreign currency translation of the financial statements of subsidiaries outside the Euro zone. (b)These amounts include changes in accrued interest balances and fair value adjustments.
Summary of Debt by Type Valuation of Redemption |
| 2024 | 2023 | 2022
(€ million) | Non- current | Current | Total | Non- current | Current | Total | Non- current | Current | Total
Bond issues | 11,876 | 2,716 | 14,592 | 14,416 | 718 | 15,134 | 15,044 | 3,817 | 18,861
Other bank borrowings | 64 | 1,290 | 1,354 | 130 | 1,118 | 1,248 | 99 | 187 | 286
Other borrowings | — | 3 | 3 | — | 6 | 6 | — | 6 | 6
Bank credit balances | — | 209 | 209 | — | 203 | 203 | — | 168 | 168
Interest rate and currency derivatives used to manage debt | — | 13 | 13 | — | (18) | (18) | — | (48) | (48)
Total debt | 11,940 | 4,231 | 16,171 | 14,546 | 2,027 | 16,573 | 15,143 | 4,130 | 19,273
Cash and cash equivalents | — | (7,441) | (7,441) | — | (8,710) | (8,710) | — | (12,736) | (12,736)
Interest rate and currency derivatives used to manage cash and cash equivalents | — | 76 | 76 | — | (28) | (28) | — | (45) | (45)
Net debt(a) | 11,940 | (3,134) | 8,806 | 14,546 | (6,711) | 7,835 | 15,143 | (8,651) | 6,492
(a)Net debt does not include lease liabilities (see the maturity schedule in Note D.17.2.)
Summary of Bond Issues | Bond issues denominated in euros carried out by Sanofi are as follows:
Issuer | ISIN code | Issue date | Maturity | Annual interest rate | Amount (€ million) | Type
Sanofi | FR0013505104 | March 2020 | April 2025 | 1.000% | 1,000 | EMTN program
Sanofi | FR0014009KS6 | April 2022 | April 2025 | 0.875% | 850 | Standalone Prospectus
Sanofi | FR0012969038 | September 2015 | September 2025 | 1.500% | 750 | EMTN program
Sanofi | FR0013324340 | March 2018 | March 2026 | 1.000% | 1,500 | EMTN program
Sanofi | FR0012146801 | September 2014 | September 2026 | 1.750% | 1,510 | EMTN program
Sanofi | FR0013201639 | September 2016 | January 2027 | 0.500% | 1,150 | EMTN program
Sanofi | FR0013144003 | April 2016 | April 2028 | 1.125% | 700 | EMTN program
Sanofi | FR0013409844 | March 2019 | March 2029 | 0.875% | 650 | EMTN program
Sanofi | FR0014009KQ0 | April 2022 | April 2029 | 1.250% | 650 | Standalone Prospectus
Sanofi | FR0013324357 | March 2018 | March 2030 | 1.375% | 2,000 | EMTN program
Sanofi | FR0013505112 | March 2020 | April 2030 | 1.500% | 1,000 | EMTN program
Sanofi | FR0013409851 | March 2019 | March 2034 | 1.250% | 500 | EMTN program
Sanofi | FR0013324373 | March 2018 | March 2038 | 1.875% | 1,250 | EMTN program
Bond issues denominated in US dollars carried out by Sanofi under the public bond issue program (shelf registration statement) registered with the US Securities and Exchange Commission (SEC) comprise:
Issuer | ISIN code | Issue date | Maturity | Annual interest rate | Amount ($ million) | Type
Sanofi | US801060AD60 | June 2018 | June 2028 | 3.625% | 1,000 | SEC registered
Summary of Debt by Maturity at Value on Redemption |
December 31, 2024 |  | Current | Non-current
(€ million) | Total | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 and later
Bond issues | 14,592 | 2,716 | 3,010 | 1,150 | 1,666 | 1,300 | 4,750
Other bank borrowings | 1,354 | 1,290 | 32 | 1 | 1 | 1 | 29
Other borrowings | 3 | 3 | — | — | — | — | —
Bank credit balances | 209 | 209 | — | — | — | — | —
Interest rate and currency derivatives used to manage debt | 13 | 13 | — | — | — | — | —
Total debt | 16,171 | 4,231 | 3,042 | 1,151 | 1,667 | 1,301 | 4,779
Cash and cash equivalents | (7,441) | (7,441) | — | — | — | — | —
Interest rate and currency derivatives used to manage cash and cash equivalents | 76 | 76 | — | — | — | — | —
Net debt(a) | 8,806 | (3,134) | 3,042 | 1,151 | 1,667 | 1,301 | 4,779
(a)Net debt does not include lease liabilities, which amounted to €1,906 million as of December 31, 2024; €2,030 million as of December 31, 2023; and €2,181 million as of December 31, 2022 (see the maturity analysis at Note D.17.2.). As of December 31, 2024, the main undrawn confirmed general-purpose credit facilities at holding company level amounted to €8 billion, half of which expired in 2027 and the other half of which expires in 2030. As of December 31, 2024, no single counterparty represented more than 6% of Sanofi’s undrawn confirmed credit facilities.
December 31, 2023 |  | Current | Non-current
(€ million) | Total | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 and later
Bond issues | 15,134 | 718 | 2,600 | 3,010 | 1,150 | 1,606 | 6,050
Other bank borrowings | 1,248 | 1,118 | 98 | 1 | 1 | 1 | 29
Other borrowings | 6 | 6 | — | — | — | — | —
Bank credit balances | 203 | 203 | — | — | — | — | —
Interest rate and currency derivatives used to manage debt | (18) | (18) | — | — | — | — | —
Total debt | 16,573 | 2,027 | 2,698 | 3,011 | 1,151 | 1,607 | 6,079
Cash and cash equivalents | (8,710) | (8,710) | — | — | — | — | —
Interest rate and currency derivatives used to manage cash and cash equivalents | (28) | (28) | — | — | — | — | —
Net debt | 7,835 | (6,711) | 2,698 | 3,011 | 1,151 | 1,607 | 6,079
December 31, 2022 |  | Current | Non-current
(€ million) | Total | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 and later
Bond issues | 18,861 | 3,817 | 600 | 2,600 | 4,160 | — | 7,684
Other bank borrowings | 286 | 187 | 61 | — | — | — | 38
Other borrowings | 6 | 6 | — | — | — | — | —
Bank credit balances | 168 | 168 | — | — | — | — | —
Interest rate and currency derivatives used to manage debt | (48) | (48) | — | — | — | — | —
Total debt | 19,273 | 4,130 | 661 | 2,600 | 4,160 | — | 7,722
Cash and cash equivalents | (12,736) | (12,736) | — | — | — | — | —
Interest rate and currency derivatives used to manage cash and cash equivalents | (45) | (45) | — | — | — | — | —
Net debt | 6,492 | (8,651) | 661 | 2,600 | 4,160 | — | 7,722
Summary of Debt by Interest Rate | The table below splits net debt between fixed and floating rate, and by maturity, as of December 31, 2024. The figures shown are values on redemption, before the effects of derivative instruments:
(€ million) | Total | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 and later
Fixed-rate debt | 14,592 | 2,716 | 3,010 | 1,150 | 1,666 | 1,300 | 4,750
of which euro | 13,626 |  |  |  |  |  |
of which US dollar | 966 |  |  |  |  |  |
% fixed-rate | 90% |  |  |  |  |  |
Floating-rate debt | 1,566 | 1,502 | 32 | 1 | 1 | 1 | 29
of which euro | — |  |  |  |  |  |
of which US dollar | 1,221 |  |  |  |  |  |
% floating-rate | 10% |  |  |  |  |  |
Debt | 16,158 | 4,218 | 3,042 | 1,151 | 1,667 | 1,301 | 4,779
Cash and cash equivalents | (7,441) | (7,441) | — | — | — | — | —
of which euro | (2,945) |  |  |  |  |  |
of which US dollar | (4,204) |  |  |  |  |  |
% floating-rate | 100% |  |  |  |  |  |
Net debt | 8,717 | (3,223) | 3,042 | 1,151 | 1,667 | 1,301 | 4,779
To optimize the cost of debt or reduce the volatility of debt and manage its exposure to financial foreign exchange risk, Sanofi uses derivative instruments (interest rate swaps, currency swaps, foreign exchange swaps and forward contracts) that alter the fixed/floating rate split and the currency split of its net debt:
(€ million) | Total | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 and later
Fixed-rate debt | 11,098 | (778) | 3,010 | 1,150 | 1,666 | 1,300 | 4,750
of which euro | 11,098 |  |  |  |  |  |
of which US dollar | — |  |  |  |  |  |
% fixed-rate | 69% |  |  |  |  |  |
Floating-rate debt | 5,074 | 5,010 | 32 | 1 | 1 | 1 | 29
of which euro | 174 |  |  |  |  |  |
of which US dollar | 3,507 |  |  |  |  |  |
% floating-rate | 31% |  |  |  |  |  |
Debt | 16,171 | 4,231 | 3,042 | 1,151 | 1,667 | 1,301 | 4,779
Cash and cash equivalents | (7,365) | (7,365) | — | — | — | — | —
of which euro | (3,987) |  |  |  |  |  |
of which US dollar | (1,005) |  |  |  |  |  |
of which Singapore dollar | (822) |  |  |  |  |  |
% floating-rate | 100% |  |  |  |  |  |
Net debt | 8,806 | (3,134) | 3,042 | 1,151 | 1,667 | 1,301 | 4,779
Summary of Interest Rate of Net Debt at Value on Redemption | The table below shows the fixed/floating rate split of net debt at value on redemption after taking account of derivative instruments as of December 31, 2023 and December 31, 2022:
(€ million) | 2023 | % | 2022 | %
Fixed-rate debt | 11,382 | 69% | 16,386 | 85%
Floating-rate debt | 5,191 | 31% | 2,886 | 15%
Debt | 16,573 | 100% | 19,273 | 100%
Cash and cash equivalents | (8,738) |  | (12,781) |
Net debt | 7,835 |  | 6,492 |
Summary of Interest Rate Fluctuations of Debt Net of Cash and Cash Equivalents | The projected full-year sensitivity of net debt to interest rate fluctuations for 2025 is as follows:
Change in short-term interest rates | Impact on pre-tax net income (€ million) | Impact on pre-tax income/(expense) recognized directly in equity (€ million)
+100 bp | 34 | —
+25 bp | 8 | —
-25 bp | (8) | —
-100 bp | (34) | —
Summary of Debt by Currency Before and After Derivative Instrument | The table below shows net debt by currency at December 31, 2024, before and after derivative instruments contracted to convert the foreign-currency net debt of exposed entities into their functional currency:
(€ million) | Before derivative instruments | After derivative instruments
Euro | 10,681 | 7,285
US dollar | (2,017) | 2,502
Singapore dollar | (3) | (822)
Hungarian forint | — | (641)
Chinese yuan renminbi | (10) | 226
Other currencies | 65 | 256
Net debt | 8,717 | 8,806
Summary of Debt by Currency After Derivative Instruments | The table below shows net debt by currency at December 31, 2023 and 2022, after derivative instruments contracted to convert the foreign currency net debt of exposed entities into their functional currency:
(€ million) | 2023 | 2022
Euro | 6,852 | 10,489
US dollar | 1,169 | (2,404)
Other currencies | (186) | (1,593)
Net debt | 7,835 | 6,492
Summary of Market Value of Net Debt | The market value of Sanofi’s debt, net of cash and cash equivalents and derivatives and excluding accrued interest, is as follows:
(€ million) | 2024 | 2023 | 2022
Market value | 8,165 | 7,086 | 5,227
Value on redemption | 8,806 | 7,835 | 6,492
Amount of Future Undiscounted Contractual Cash Flows Relating to Debt and Derivative Instruments Designated as Hedges of Debt | The table below shows the amount of future undiscounted contractual cash flows (principal and interest) relating to debt and to derivative instruments designated as hedges of debt:
December 31, 2024 |  | Payments due by period
(€ million) | Total | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 and later
Debt | 17,077 | 4,328 | 3,226 | 1,288 | 1,780 | 1,388 | 5,067
Principal | 16,049 | 4,105 | 3,047 | 1,151 | 1,667 | 1,300 | 4,779
Interest(a) | 1,028 | 223 | 179 | 137 | 113 | 88 | 288
Net cash flows related to derivative instruments | 161 | 71 | 34 | 34 | 21 | 1 | —
Total | 17,238 | 4,399 | 3,260 | 1,322 | 1,801 | 1,389 | 5,067
(a)Interest flows are estimated on the basis of forward interest rates applicable as of December 31, 2024. The tables below show the amount of future undiscounted contractual cash flows (principal and interest) relating to debt and to derivative instruments designated as hedges of debt as of December 31, 2023 and 2022:
December 31, 2023 |  | Payments due by period
(€ million) | Total | 2024 | 2025 | 2026 | 2026 | 2028 | 2029 and later
Debt | 17,710 | 2,153 | 2,912 | 3,187 | 1,285 | 1,719 | 6,454
Principal | 16,468 | 1,917 | 2,703 | 3,011 | 1,151 | 1,607 | 6,079
Interest(a) | 1,242 | 236 | 209 | 176 | 134 | 112 | 375
Net cash flows related to derivative instruments | 143 | 47 | 32 | 23 | 24 | 16 | 1
Total | 17,853 | 2,200 | 2,944 | 3,210 | 1,309 | 1,735 | 6,455
(a)Interest flows are estimated on the basis of forward interest rates applicable as of December 31, 2023.
December 31, 2022 |  | Payments due by period
(€ million) | Total | 2023 | 2024 | 2025 | 2026 | 2026 | 2028 and later
Debt | 20,408 | 4,206 | 868 | 2,803 | 3,184 | 1,283 | 8,064
Principal | 18,932 | 3,928 | 661 | 2,601 | 3,011 | 1,151 | 7,580
Interest(a) | 1,476 | 278 | 207 | 202 | 173 | 132 | 484
Net cash flows related to derivative instruments | 209 | 24 | 60 | 38 | 31 | 31 | 25
Total | 20,617 | 4,230 | 928 | 2,841 | 3,215 | 1,314 | 8,089
(a)Interest flows are estimated on the basis of forward interest rates applicable as of December 31, 2022.
Disclosure of Lease Liabilities | A maturity analysis of lease liabilities as of December 31, 2024, 2023 and 2022 is set forth below:
|  | Undiscounted future minimum lease payments
(€ million) | Total | Less than 1 year | From 1 to 3 years | From 3 to 5 years | More than 5 years | Discounting effect
Total lease liabilities as of December 31, 2024(a) | 1,906 | 377 | 498 | 386 | 819 | (174)
Total lease liabilities as of December 31, 2023 | 2,030 | 291 | 448 | 360 | 989 | (58)
Total lease liabilities as of December 31, 2022 | 2,181 | 320 | 515 | 436 | 1,129 | (219)
(a)2024 amounts exclude Opella discontinued operations, while 2023 and 2022 include them. Lease liabilities include leases relating to real estate assets located at Cambridge, MA (United States), which have a lease term of 15 years.

X
- Definition The disclosure of detailed information about borrowings. [Refer: Borrowings] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 7 -IssueDate 2023-01-01 -Paragraph 7 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_7&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of changes in financial position [text block] + References No definition available. + Details
Name: | sny_DisclosureOfChangesInFinancialPositionTableTextBlock
Namespace Prefix: | sny_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of debt by currency at value of redemption after derivative instruments. + References No definition available. + Details
Name: | sny_DisclosureOfDebtByCurrencyAtValueOfRedemptionAfterDerivativeInstrumentsTableTextBlock
Namespace Prefix: | sny_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of debt by currency at value of redemption before and after derivative instruments. + References No definition available. + Details
Name: | sny_DisclosureOfDebtByCurrencyAtValueOfRedemptionBeforeAndAfterDerivativeInstrumentsTableTextBlock
Namespace Prefix: | sny_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of debt by interest rate at value of redemption after taking account of derivative instruments N1 N2. + References No definition available. + Details
Name: | sny_DisclosureOfDebtByInterestRateAtValueOfRedemptionAfterTakingAccountOfDerivativeInstrumentsN1N2TableTextBlock
Namespace Prefix: | sny_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of debt by interest rate at value of redemption and by maturity. + References No definition available. + Details
Name: | sny_DisclosureOfDebtByInterestRateAtValueOfRedemptionAndByMaturityExplanatoryTableTextBlock
Namespace Prefix: | sny_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of debt by maturity at value of redemption. + References No definition available. + Details
Name: | sny_DisclosureOfDebtByMaturityAtValueOfRedemptionExplanatoryTableTextBlock
Namespace Prefix: | sny_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of debt net of cash and cash equivalents by type at value on redemption. + References No definition available. + Details
Name: | sny_DisclosureOfDebtNetOfCashAndCashEquivalentsByTypeAtValueOnRedemptionExplanatoryTableTextBlock
Namespace Prefix: | sny_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure Of Detail Of Bonds Issued Explanatory + References No definition available. + Details
Name: | sny_DisclosureOfDetailOfBondsIssuedExplanatoryTableTextBlock
Namespace Prefix: | sny_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of market value of net debt [Text Block] + References No definition available. + Details
Name: | sny_DisclosureOfMarketValueOfNetDebtTableTextBlock
Namespace Prefix: | sny_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of maturity analysis of future undiscounted cash flows. + References No definition available. + Details
Name: | sny_DisclosureOfMaturityAnalysisOfFutureUndiscountedCashFlowsExplanatoryTableTextBlock
Namespace Prefix: | sny_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure Of Maturity Analysis Of Lease Payments [Table Text Block] + References No definition available. + Details
Name: | sny_DisclosureOfMaturityAnalysisOfLeasePaymentsTableTextBlock
Namespace Prefix: | sny_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of reconciliation of carrying amount to value on redemption [text block] + References No definition available. + Details
Name: | sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTableTextBlock
Namespace Prefix: | sny_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of sensitivity analysis on long-term borrowings and debt securities assuming a 1% increase and decrease in interest rates. + References No definition available. + Details
Name: | sny_DisclosureOfSensitivityAnalysisOnLongTermBorrowingsAndDebtSecuritiesAssumingA1IncreaseAndDecreaseInInterestRatesTableTextBlock
Namespace Prefix: | sny_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Financial Instruments [Abstract] + References No definition available. + Details
Name: | sny_FinancialInstrumentsAbstract
Namespace Prefix: | sny_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration